All doses of Eli Lilly & Co.’s blockbuster new drugs to treat diabetes and weight loss are available in the US after more than a year and a half of shortages.. The Food and Drug Administration ...

Drug manufacturer Eli Lilly announced Tuesday that its flagship weight loss medication, Zepbound, is now available for patient use.. Tirzepatide, its active ingredient, had been approved by the US ...

All doses of Eli Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro are now available, the U.S. Food and Drug Administration's updated shortage list showed on Friday.

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...

Pricey weight loss drugs trending among celebrities, costs out of reach for many Americans 05:32. A drug used to treat Type 2 diabetes has become wildly popular due to one of its side effects ...

The newly approved weight-loss medication known as Zepbound is now available for patients to take, drug maker Eli Lilly announced Tuesday. "Today opens another chapter for adults living with ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Lilly's weight loss drug Zepbound prevents diabetes as well as helping people lose weight, company claims Hotspots ranked Start the day smarter ☀️ Funniest cap messages Get the USA TODAY app ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk and potential applications for addiction treatment.

Joanie Knight has a message for anyone considering drugs like Ozempic or Wegovy, which have become popular for the dramatic weight loss they can help people achieve. “I wish I never touched it ...

Weight loss drugs help manage blood sugar levels by mimicking two important hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) that regulate insulin ...

Wegovy, a drug which has seen massive demand in recent years due its weight loss properties, will now be made available to Medicare patients to help reduce their risk of heart attacks and strokes.